# Adsorption of Cell-free Diphtheria and Tetanus (Three-component) Combined With Vaccine Phase III Clinical Trial

> **NCT07112144** · PHASE3 · RECRUITING · sponsor: **Changchun BCHT Biotechnology Co.** · enrollment: 1650 (estimated)

## Conditions studied

- Prevent Whooping Cough
- Prevent Diphtheria
- Prevent Tetanus

## Interventions

- **BIOLOGICAL:** DTacP
- **BIOLOGICAL:** DTaP
- **BIOLOGICAL:** DTacP-IPV/Hib

## Key facts

- **NCT ID:** NCT07112144
- **Lead sponsor:** Changchun BCHT Biotechnology Co.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-06-13
- **Primary completion:** 2032-06
- **Final completion:** 2032-06
- **Target enrollment:** 1650 (ESTIMATED)
- **Last updated:** 2025-08-08

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07112144

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07112144, "Adsorption of Cell-free Diphtheria and Tetanus (Three-component) Combined With Vaccine Phase III Clinical Trial". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT07112144. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*